Non-coding RNAs and type 2 diabetes mellitus

References

• Al-Kafaji, G., et al., 2015. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Molecular medicine reports, 12 (5), 7485–7490.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji, G., et al., 2016. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: a potential blood-based biomarker. Experimental and therapeutic medicine, 12 (2), 815–822.
   PubMed Web of Science ®Google Scholar
• Ardekani, A.M. and Naeini, M.M., 2010. The role of microRNAs in human diseases. Avicenna journal of medical biotechnology, 2 (4), 161–179.
   PubMedGoogle Scholar
• Baldeon, R.L., et al., 2015. Type 2 diabetes monocyte microRNA and mRNA expression: dyslipidemia associates with increased differentiation-related genes but not inflammatory activation. PLoS one, 10 (6), e0129421.
   PubMed Web of Science ®Google Scholar
• Belgardt, B.F., et al., 2015. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nature medicine, 21 (6), 619–627.
   PubMed Web of Science ®Google Scholar
• Carter, G., et al., 2015. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus. BBA clinical, 4, 102–107.
   PubMed Web of Science ®Google Scholar
• Cui, X., et al., 2018. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes. Metabolism: clinical and experimental, 78, 95–105.
   PubMed Web of Science ®Google Scholar
• De Candia, P., et al., 2017. A unique plasma microRNA profile defines type 2 diabetes progression. PLoS one, 12 (12), e0188980.
   PubMed Web of Science ®Google Scholar
• Dong, L., et al., 2019. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells. Cell biology international, 43 (5), 553–564.
   PubMed Web of Science ®Google Scholar
• Erfanian Omidvar, M., et al., 2019. Clinical significance of long noncoding RNA VIM-AS1 and CTBP1-AS2 expression in type 2 diabetes. Journal of cellular biochemistry, 120 (6), 9315–9323.
   PubMed Web of Science ®Google Scholar
• Ghaedi, H., et al., 2018. Genetic variants in long noncoding RNA H19 and MEG3 confer risk of type 2 diabetes in an Iranian population. Gene, 675, 265–271.
   PubMed Web of Science ®Google Scholar
• Greco, S., Gaetano, C., and Martelli, F., 2019. Long noncoding competing endogenous RNA networks in age-associated cardiovascular diseases. International journal of molecular sciences, 20 (12), 3079.
   PubMed Web of Science ®Google Scholar
• Guglielmi, V., et al., 2017. MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects. Nutrition and healthy aging, 4 (2), 141–145.
   PubMedGoogle Scholar
• Hangauer, M.J., Vaughn, I.W., and Mcmanus, M.T., 2013. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS genetics, 9 (6), e1003569.
   PubMed Web of Science ®Google Scholar
• Herrera, B.M., et al., 2009. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of type 2 diabetes. BMC medical genomics, 2 (1), 54.
   PubMedGoogle Scholar
• Hu, F., et al., 2019. MiR-495 regulates macrophage M1/M2 polarization and insulin resistance in high-fat diet-fed mice via targeting FTO. Pflugers archiv : European journal of physiology, 471 (11-12), 1529–1537.,
   PubMed Web of Science ®Google Scholar
• Hu, W., et al., 2020. The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in adipose tissue from type 2 diabetes individuals with obesity. Journal of diabetes research, 2020, 1–14.,
   Web of Science ®Google Scholar
• Jain, S., et al., 2017. Long non-coding RNA: functional agent for disease traits. RNA biology, 14 (5), 522–535.
   PubMed Web of Science ®Google Scholar
• Jiang, Q., et al., 2017. Plasma miR-21 expression: an indicator for the severity of type 2 diabetes with diabetic retinopathy. Bioscience reports, 37, BSR20160589.
   PubMed Web of Science ®Google Scholar
• Kamalden, T.A., et al., 2017. Exosomal microRNA-15a transfer from the pancreas augments diabetic complications by inducing oxidative stress. Antioxidants & redox signaling, 27 (13), 913–930.
   PubMed Web of Science ®Google Scholar
• Karolina, D.S., et al., 2011. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS one, 6 (8), e22839.
   PubMed Web of Science ®Google Scholar
• Kokkinopoulou, I., et al., 2019. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals. Endocrine, 66 (2), 226–239.
   PubMed Web of Science ®Google Scholar
• Lee, H.W., et al., 2017. Absence of miR-146a in podocytes increases risk of diabetic glomerulopathy via up-regulation of ErbB4 and Notch-1. The journal of biological chemistry, 292 (2), 732–747.
   PubMed Web of Science ®Google Scholar
• Liu, H.N., et al., 2018. Serum microRNA-221 as a biomarker for diabetic retinopathy in patients associated with type 2 diabetes. International journal of ophthalmology, 11, 1889–1894.
   PubMed Web of Science ®Google Scholar
• Liu, S.-X., et al., 2019. Exercise reduces insulin resistance in type 2 diabetes mellitus via mediating the lncRNA MALAT1/microRNA-382-3p/resistin axis. Molecular therapy. Nucleic acids, 18, 34–44.
   PubMedGoogle Scholar
• Locke, J.M., et al., 2014. Increased expression of miR-187 in human islets from individuals with type 2 diabetes is associated with reduced glucose-stimulated insulin secretion. Diabetologia, 57 (1), 122–128.
   PubMed Web of Science ®Google Scholar
• Ma, Q., et al., 2020. Association between lncRNA and GCKR gene in type 2 diabetes mellitus. Clinica chimica acta, 501, 66–71.
   PubMed Web of Science ®Google Scholar
• Marycz, K., et al., 2016. Macroautophagy and selective mitophagy ameliorate chondrogenic differentiation potential in adipose stem cells of equine metabolic syndrome: new findings in the field of progenitor cells differentiation. Oxidative medicine and cellular longevity, 2016, 1–18.
   Web of Science ®Google Scholar
• Mazloom, H., et al., 2015. Downregulated microRNA-155 expression in peripheral blood mononuclear cells of type 2 diabetic patients is not correlated with increased inflammatory cytokine production. Cytokine, 76 (2), 403–408.
   PubMed Web of Science ®Google Scholar
• Moran, I., et al., 2012. Human beta cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell metabolism, 16, 435–448.
   PubMed Web of Science ®Google Scholar
• Nawrocka, D., et al., 2017. Spirulina platensis improves mitochondrial function impaired by elevated oxidative stress in adipose-derived mesenchymal stromal cells (ASCs) and intestinal epithelial cells (IECs), and enhances insulin sensitivity in equine metabolic syndrome (EMS) horses. Marine drugs, 15 (8), 237.
   PubMed Web of Science ®Google Scholar
• Pielok, A. and Marycz, K., 2020. Non-coding RNAs as potential novel biomarkers for early diagnosis of hepatic insulin resistance. International journal of molecular sciences, 21 (11), 4182.
   PubMed Web of Science ®Google Scholar
• Qi, M., et al., 2017. Analysis of long non-coding RNA expression of lymphatic endothelial cells in response to type 2 diabetes. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 41 (2), 466–474.
   PubMedGoogle Scholar
• Ruan, Y., et al., 2018. Circulating LncRNAs analysis in patients with type 2 diabetes reveals novel genes influencing glucose metabolism and islet β-cell function. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 46 (1), 335–350.
   PubMedGoogle Scholar
• Saeidi, L., et al., 2018. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus. Molecular biology reports, 45 (6), 2601–2608.
   PubMed Web of Science ®Google Scholar
• Salunkhe, V.A., et al., 2017. MiR-335 overexpression impairs insulin secretion through defective priming of insulin vesicles. Physiological reports, 5 (21), e13493.
   PubMed Web of Science ®Google Scholar
• Sebastiani, G., et al., 2015. MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion. Acta diabetologica, 52 (3), 523–530.
   PubMed Web of Science ®Google Scholar
• Sucharita, S., et al., 2018. The role of circulating microRNA in the regulation of beta cell function and insulin resistance among indians with type 2 diabetes. Indian journal of endocrinology and metabolism, 22 (6), 770–773.
   PubMedGoogle Scholar
• Tello-Flores, V.A., et al., 2020. Altered levels of MALAT1 and H19 derived from serum or serum exosomes associated with type-2 diabetes. Non-coding RNA research, 5 (2), 71–76.
   PubMed Web of Science ®Google Scholar
• Vatandoost, N., et al., 2015. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats. Gene, 572 (1), 95–100.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2018. Clinical significance of serum lncRNA cancer susceptibility candidate 2 (CASC2) for chronic renal failure in patients with type 2 diabetes. Medical science monitor : international medical journal of experimental and clinical research, 24, 6079–6084.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2019. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. International journal of molecular sciences, 20 (22), 5758.
   PubMed Web of Science ®Google Scholar
• Wu, Y., et al., 2019. A comprehensive competitive endogenous RNA network pinpoints key molecules in diabetic retinopathy. Molecular medicine reports, 19, 851–860.
   PubMed Web of Science ®Google Scholar
• Xie, Y., et al., 2017. Urinary exosomal microRNA profiling in incipient type 2 diabetic kidney disease. Journal of diabetes research, 2017, 1–10.
   Web of Science ®Google Scholar
• Yan, B., et al., 2015. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. Circulation research, 116 (7), 1143–1156.
   PubMed Web of Science ®Google Scholar
• Yu, W., et al., 2017. LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with type 2 diabetes. Behavioural neurology, 2017, 2941297.
   PubMed Web of Science ®Google Scholar
• Zha, T., et al., 2019. Role of long non-coding RNA (LncRNA) LINC-PINT downregulation in cardiomyopathy and retinopathy progression among patients with type 2 diabetes. Medical science monitor : international medical journal of experimental and clinical research, 25, 8509–8514.
   PubMed Web of Science ®Google Scholar
• Zhang, J., et al., 2017. Long non-coding RNA MIAT acts as a biomarker in diabetic retinopathy by absorbing miR-29b and regulating cell apoptosis. Bioscience reports, 37 (2), BSR20170036.
   PubMed Web of Science ®Google Scholar
• Zhao, Z., et al., 2017. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus. Acta diabetologica, 54 (3), 237–245.,
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Ley, S.H., and Hu, F.B., 2018. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature reviews. Endocrinology, 14 (2), 88–98.
   PubMed Web of Science ®Google Scholar
• Zhou, J., et al., 2014. Comparative microRNA expression profiles of cynomolgus monkeys, rat, and human reveal that mir-182 is involved in T2D pathogenic processes. Journal of diabetes research, 2014, 760397.
   PubMed Web of Science ®Google Scholar
• Zhou, M., et al., 2019. Long non-coding RNA metallothionein 1 pseudogene 3 promotes p2y12 expression by sponging miR-126 to activate platelet in diabetic animal model. Platelets, 30 (4), 452–459.
   PubMed Web of Science ®Google Scholar